ALB and Ecchymosis: Xiao et al. further studied patients routinely administered rivaroxaban as anticoagulation therapy, with their results indicating that age, BMI, history of hypertension, mean arterial pressure, albumin, and hemoglobin levels were independent risk factors for ecchymosis development (23).